LEUKERAN (Aspen Global Inc.)
Welcome to the PulseAid listing for the LEUKERAN drug offered from Aspen Global Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Aspen Global Inc. |
| NON-PROPRIETARY NAME: | chlorambucil |
| SUBSTANCE NAME: | CHLORAMBUCIL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1985-02-13 |
| END MARKETING DATE: | 0000-00-00 |
LEUKERAN HUMAN PRESCRIPTION DRUG Details:
| Item Description | LEUKERAN from Aspen Global Inc. |
| LABELER NAME: | Aspen Global Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2(mg/1) |
| START MARKETING DATE: | 1985-02-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 76388-635_7537f598-461c-4f23-8b37-442c621b7a51 |
| PRODUCT NDC: | 76388-635 |
| APPLICATION NUMBER: | NDA010669 |
Other CHLORAMBUCIL Pharmaceutical Manufacturers / Labelers:
